COVID-19
COVID-19 has caused over three times more deaths than flu or pneumonia in England and Wales
October 8, 2020Medical Communications, Research and Development COVID-19, UK, flu
Newly released data has revealed that COVID-19 has resulted in many more deaths than influenza or pneumonia in England and …
Gilead to meet rising remdesivir demand in Europe with new supply deal
October 8, 2020Manufacturing and Production COVID-19, Europe, Gilead
The European Commission (EC) has signed a new joint procurement agreement (JPA) with pharma firm Gilead to improve access to …
EMA launches rolling regulatory review of Pfizer and BioNTech’s COVID-19 vaccine
October 7, 2020Research and Development, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine
European Medicines Agency has launched a “rolling review” of the promising COVID-19 vaccine candidate BNT162b2 currently in development from BioNTech …
Pharmafile.com’s weekly COVID-19 news round-up
October 7, 2020Research and Development COVID, COVID-19, corornavirus
The coronavirus news this week focuses on treatments, with Enlivex Therapeutics releasing positive data for its therapy Allocetra as a …
Remdesivir has a “favourable” benefit/risk profile in COVID-19 but more data needed, DSRU review argues
October 5, 2020Research and Development, Sales and Marketing COVID-19, Drug Safety Research Unit, pharma, remdesivir
Southampton’s Drug Safety Research Unit (DSRU) has released a systematic benefit/risk analysis of Gilead’s antiviral drug remdesivir in the treatment …
IGT Biologika’s COVID-19 vaccine becomes third in Germany to be approved for human trials
October 2, 2020Medical Communications, Research and Development COVID-19, IDT Biologika, Vaccine
German biotech IDT Biologika has become the third company in the country to secure approval from the nation’s vaccine regulator …
Donald and Melania Trump test positive for COVID-19
October 2, 2020Medical Communications COVID-19, Trump, coronavirus
President Donald Trump and First Lady Melania Trump have both tested positive for COVID-19. Trump tweeted: “Tonight, @FLOTUS and I …
Novel prophylactic nasal spray reduced COVID-19 replication by 96% in animal studies
September 28, 2020Research and Development, Sales and Marketing COVID-19, Ena Respiratory, Nasal Spray
Australian biotech Ena Respiratory has revealed new data demonstrating that its novel nasal spray almost halted replication of the SARS-CoV-2 …
GSK confirms deal to supply 300 million COVID-19 vaccine doses to the EU
September 25, 2020Manufacturing and Production, Medical Communications COVID-19, EU, GSK, Vaccine
GlaxoSmithKline has confirmed a new COVID-19 vaccine supply deal to deliver 300 million doses of its candidate to the European …
Science community calls for transparency on AstraZeneca’s halted US COVID-19 vaccine trial
September 23, 2020Research and Development AstraZeneca, COVID-19, Vaccine
The halting of AstraZeneca’s COVID-19 vaccine trial around the world was cause for much initial concern over the eventual safety …
Pharmafile.com’s weekly COVID-19 news round-up
September 23, 2020Research and Development COVID-19, coronavirus
The coronavirus news this week largely focuses on clinical trial results, with Pfizer saying that participants in a late-stage trial …
CDC says its updated guidance stating coronavirus spreads through the air was posted in “error”
September 22, 2020Manufacturing and Production CDC, COVID-19
The US Centers for Disease Control and Prevention (CDC) has removed its guidance that said coronavirus was transmitted through the …
CDC says nearly 11,000 Americans have been exposed to COVID-19 on flights
September 21, 2020Sales and Marketing COVID-19, air travel, coronavirus
The Centers for Disease Control and Prevention has identified nearly 11,000 people who were potentially exposed to coronavirus while flying. …
Roche says its rheumatoid arthritis drug reduces the need for ventilators in coronavirus patients
September 18, 2020Medical Communications COVID-19, Roche
Roche says that its Actermra/Roactemra drugs reduce the likelihood that coronavirus patients with virus-related pneumonia will need to be put …
One in seven Russian COVID-19 vaccine recipients display side-effects, says Health Minister
September 18, 2020Medical Communications, Research and Development COVID-19, Russia, Sputnik V, Vaccine
Around one in seven patients who have received Russia’s vaccine against COVID-19 have displayed side-effects in clinical studies, according to …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
